TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 SELECTIVELY REGULATE NEUTROPHIL FUNCTION IN-VITRO

被引:63
作者
MULLEN, PG
WINDSOR, ACJ
WALSH, CJ
FOWLER, AA
SUGERMAN, HJ
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,RICHMOND,VA 23298
[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PATHOL,RICHMOND,VA 23298
关键词
D O I
10.1006/jsre.1995.1020
中图分类号
R61 [外科手术学];
学科分类号
摘要
The neutrophil is an important effector cell of the host response to sepsis. Tumor necrosis factor-alpha) (TNF-alpha), a cytokine mediator of the septic response, is rapidly released following endotoxemia or gram-negative bacteremia. Interleukin-g (IL-6) is another cytokine mediator of the host response to sepsis whose role is less well understood than that of TNF-alpha. It is known to be elevated in gram-negative sepsis, where peak levels have been correlated with mortality. This study examined the effect of IL-6 alone and in combination with TNF-alpha on three neutrophil functions-CD18 adhesion receptor expression, phagocytosis, and superoxide anion generation. Neutrophils from human volunteers were incubated with amounts of IL-6 ranging from 10 to 1000 ng/ml. At a concentration of 1000 ng/ml, IL-6 increased neutrophil phagocytosis of opsonized bacteria (826 +/- 255 x 10(3) MESF vs 552 +/- 103 MESF, P < 0.05) and also increased neutrophil superoxide anion generation (18.41 +/- 1.86 vs 12.6 nmol O-2(-)/10(8) PMN/10 min, P < 0.05). Lesser amounts of IL-6 had no effect on phagocytosis or superoxide generation. IL-6 did not increase neutrophil CD18 adhesion receptor expression. Combining IL-6 with TNF-alpha at doses of 100 ng/ml and 100 U/ml, respectively, neutrophil phagocytosis (221 +/- 455 MESF vs 552 +/- 103 MESF) and superoxide generation (23.18 +/- 1.86 vs 12.6 nmol O-2(-)/10(6) PMN/10 min) were significantly (P < 0.05) increased above control by an amount similar to that seen with 1000 U/ml TNF-alpha alone. IL-6 and TNF-alpha combined did not further increase CD18 expression over that produced by 100 U/ml TNF-alpha alone. We conclude that IL-6 selectively influences neutrophil function so that, with regard to phagocytosis and superoxide generation, the response of neutrophils to a combination of 100 ng/ml IL-6 and 100 U/ml TNF-alpha equals that produced by 1000 U/ml of TNF-alpha alone. This synergy between IL-6 and TNF-alpha may represent an important mechanism by which IL-6 potentiates the effect of TNF-alpha in vivo. (C) 1995 Academic Press, Inc.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 39 条
[1]  
ANDERSON BO, 1990, SURGERY, V108, P262
[2]   INCREASED EXPRESSION OF AN ADHESION-PROMOTING SURFACE GLYCOPROTEIN IN THE GRANULOCYTOPENIA OF HEMODIALYSIS [J].
ARNAOUT, MA ;
HAKIM, RM ;
TODD, RF ;
DANA, N ;
COLTEN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (08) :457-462
[3]  
Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
[4]   HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES [J].
CALANDRA, T ;
GERAIN, J ;
HEUMANN, D ;
BAUMGARTNER, JD ;
GLAUSER, MP .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) :23-29
[5]   INDUCTION OF A 26-KDA-PROTEIN MESSENGER-RNA IN HUMAN-CELLS TREATED WITH AN INTERLEUKIN-1-RELATED, LEUKOCYTE-DERIVED FACTOR [J].
CONTENT, J ;
DEWIT, L ;
POUPART, P ;
OPDENAKKER, G ;
VANDAMME, J ;
BILLIAU, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (02) :253-257
[6]   HEMODIALYSIS LEUKOPENIA - PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES [J].
CRADDOCK, PR ;
FEHR, J ;
DALMASSO, AP ;
BRIGHAM, KL ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :879-888
[7]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS [J].
DAMAS, P ;
REUTER, A ;
GYSEN, P ;
DEMONTY, J ;
LAMY, M ;
FRANCHIMONT, P .
CRITICAL CARE MEDICINE, 1989, 17 (10) :975-978
[8]   ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J].
FONG, YM ;
TRACEY, KJ ;
MOLDAWER, LL ;
HESSE, DG ;
MANOGUE, KB ;
KENNEY, JS ;
LEE, AT ;
KUO, GC ;
ALLISON, AC ;
LOWRY, SF ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1627-1633
[9]  
FONG YM, 1989, J IMMUNOL, V142, P2321
[10]  
GAULDIE J, 1990, J IMMUNOL, V144, P3804